Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
about
USP13 enzyme regulates Siah2 ligase stability and activity via noncatalytic ubiquitin-binding domainsExpression of drug targets in patients treated with sorafenib, carboplatin and paclitaxelRepression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma.Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.Phosphatidylinositol-3-kinase as a therapeutic target in melanomaThe X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.Melanocyte receptors: clinical implications and therapeutic relevance.Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.Tumor profiling using protein biomarker panels in malignant melanoma: application of tissue microarrays and beyond.Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system.Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology.A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes.Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors.
P2860
Q24306252-4BB60244-CBA4-40F3-9466-6B2942436D80Q28535159-D85EE72B-0841-488D-A78C-0D5143D3AE5FQ33288897-6406B6FA-649C-496C-83A8-CFE70D63DABEQ33665758-C72030AE-F625-4B57-8DD3-9D3916FE058DQ34221846-47D3CFF9-10E3-4A27-AF73-A522023CAE30Q34678882-95D3BF9E-87B0-4DD2-9D34-60DE5C3E9F85Q35606261-F6748F19-EF7D-4B76-85F7-A859517F0D4BQ35632517-B28E834D-4DA0-475E-851E-D3AD53C4398CQ35812429-0AFAF330-58CA-490B-BD39-BFD12D272F79Q36545873-748EF0DD-7027-4633-987A-4ED52E087DB9Q36954814-22D92065-5054-46B7-B5F3-86FF146BD7AEQ37288883-969071D6-9CB3-4380-8B4E-A9E98E07DC1BQ37389958-90E74E62-DD91-4A4F-92B5-D228D9686E48Q38042458-380E9A39-ECDC-440E-A0AC-4631B76A09BFQ38260461-6B82EF2E-0959-4FC6-863F-D3892EEBD0D1Q38557486-50EEC708-DFE2-44FD-8492-CEE2D1FFB203Q40008373-611F1191-2195-406C-A5F4-FCE3CF081E65Q50078523-3CE99887-26FB-4735-9337-8958824E347FQ53488547-610D3250-B6AD-497D-B91F-29449EC282CE
P2860
Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Expression of tumor necrosis f ...... receptors 1 and 2 in melanoma.
@ast
Expression of tumor necrosis f ...... receptors 1 and 2 in melanoma.
@en
type
label
Expression of tumor necrosis f ...... receptors 1 and 2 in melanoma.
@ast
Expression of tumor necrosis f ...... receptors 1 and 2 in melanoma.
@en
prefLabel
Expression of tumor necrosis f ...... receptors 1 and 2 in melanoma.
@ast
Expression of tumor necrosis f ...... receptors 1 and 2 in melanoma.
@en
P2093
P2860
P50
P1476
Expression of tumor necrosis f ...... receptors 1 and 2 in melanoma.
@en
P2093
Aaron J Berger
David L Rimm
Harriet M Kluger
Kyle A DiVito
Mary M McCarthy
Robert L Camp
Rossitza Lazova
Ruth Halaban
P2860
P304
P356
10.1158/1078-0432.CCR-06-0190
P407
P577
2006-06-01T00:00:00Z